CIRM Funded Clinical Trials
A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus
Disease Area:
Lupus, Systemic Lupus Erythematosus (SLE)
Trial Sponsor:
Fate Therapeutics, Inc.
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
